The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
Open accessAbstract
Breast cancer (BC) is the most common malignancy in women worldwide, and one of the deadliest after lung cancer. Currently, standard methods for cancer therapy including BC are surgery followed by chemotherapy or radiotherapy. However, both chemotherapy and radiotherapy often fail to treat BC due to the side effects that these therapies incur in normal tissues and organs. In recent years, various nanoparticles (NPs) have been discovered and synthesized to be able to selectively target tumor cells without causing any harm to the healthy cells or organs. Therefore, NPs-mediated targeted drug delivery systems (DDS) have become a promising technique to treat BC. In addition to their selectivity to target tumor cells and reduce side effects, NPs have other unique properties which make them desirable for cancer treatment such as low toxicity, good compatibility, ease of preparation, high photoluminescence (PL) for bioimaging in vivo, and high loadability of drugs due to their tunable surface functionalities. In this study, we summarize with a critical analysis of the most recent therapeutic studies involving various NPs-mediated DDS as alternatives for the traditional treatment approaches for BC. It will shed light on the significance of NPs-mediated DDS and serve as a guide to seeking for the ideal methodology for future targeted drug delivery for an efficient BC treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kavosi, A., Noei, S. H. G., Madani, S., Khalighfard, S., Khodayari, S., Khodayari, H., Mirzaei, M., Kalhori, M. R., Yavarian, M., Alizadeh, A. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26790-x · Cited by 95
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Carbon Nanotubes--the Route Toward Applications
Baughman, R. H., Zakhidov, A. A., & de Heer, W. A. (2002) · Science · doi:10.1126/science.1060928 · Cited by 10,267
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Quantum-Sized Carbon Dots for Bright and Colorful Photoluminescence
Sun, Y.-P., Zhou, B., Lin, Y., Wang, W., Fernando, K. A. S., Pathak, P., Meziani, M. J., Harruff, B. A., Wang, X., Wang, H., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062677d · Cited by 5,114
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
An Introduction to Electrospinning and Nanofibers
Ramakrishna, S., Fujihara, K., Teo, W.-E., Lim, T.-C., & Ma, Z. (2005) · WORLD SCIENTIFIC eBooks · doi:10.1142/5894 · Cited by 2,049
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
Shape control in gold nanoparticle synthesis
Grzelczak, M., Pérez-Juste, J., Mulvaney, P., & Liz-Marzán, L. M. (2008) · Chemical Society Reviews · doi:10.1039/b711490g · Cited by 1,911
Sparkes, I. A., Runions, J., Kearns, A., & Hawes, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.286 · Cited by 1,906
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
The cellular and molecular basis of hyperthermia
Hildebrandt, B. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00179-2 · Cited by 1,718
Marty, M., Cognetti, F., Maraninchi, D., Snyder, R., Mauriac, L., Tubiana-Hulin, M., Chan, S., Grimes, D., Antón, A., Lluch, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.173 · Cited by 1,597
Cytotoxicity of Carbon Nanomaterials: Single-Wall Nanotube, Multi-Wall Nanotube, and Fullerene
Jia, G., Wang, H., Yan, L., Wang, X., Pei, R., Yan, T., Zhao, Y., & Guo, X. (2005) · Environmental Science & Technology · doi:10.1021/es048729l · Cited by 1,404
Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery
Liu, Z., Sun, X., Nakayama-Ratchford, N., & Dai, H. (2007) · ACS Nano · doi:10.1021/nn700040t · Cited by 1,368
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery
Cheng, R., Meng, F., Deng, C., Klok, H.-A., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,354
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Gold nanoparticles: preparation, properties, and applications in bionanotechnology
Yeh, Y.-C., Creran, B., & Rotello, V. M. (2012) · Nanoscale · doi:10.1039/c1nr11188d · Cited by 1,346
Kim, J., Kim, H. S., Lee, N., Kim, T., Kim, H., Yu, T., Song, I. C., Moon, W. K., & Hyeon, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802469 · Cited by 1,220
Novel chitin and chitosan nanofibers in biomedical applications
Jayakumar, R., Prabaharan, M., Nair, S. V., & Tamura, H. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.11.001 · Cited by 1,013
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
An Introduction to Electrospinning and Nanofibers
Ramakrishna, S., Fujihara, K., Teo, W. E., et al. (2005) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812567611 · Cited by 992
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Self-citationCarbon-Based Nanomaterials: Multifunctional Materials for Biomedical Engineering
Cha, C., Shin, S. R., Annabi, N., Dokmeci, M. R., & Khademhosseini, A. (2013) · ACS Nano · doi:10.1021/nn401196a · Cited by 825
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813
Mesoporous Silica Nanoparticles for Intracellular Delivery of Membrane-Impermeable Proteins
Slowing, I. I., Trewyn, B. G., & Lin, V. S.-Y. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0719780 · Cited by 795
Fentiman, I. S., Fourquet, A., & Hortobagyi, G. N. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68226-3 · Cited by 744
Recent progress on the photocatalysis of carbon dots: Classification, mechanism and applications
Han, M., Zhu, S., Lu, S., Song, Y., Feng, T., Tao, S., Liu, J., & Yang, B. (2018) · Nano Today · doi:10.1016/j.nantod.2018.02.008 · Cited by 727
Side Effects of Adjuvant Treatment of Breast Cancer
Shapiro, C. L., & Recht, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442607 · Cited by 724
Polymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, F. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.11.067 · Cited by 702
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Semiconductor Quantum Dots for Bioimaging and Biodiagnostic Applications
Kairdolf, B. A., Smith, A. M., Stokes, T. H., Wang, M. D., Young, A. N., & Nie, S. (2013) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-060908-155136 · Cited by 672
Size Matters: Gold Nanoparticles in Targeted Cancer Drug Delivery
Dreaden, E. C., Austin, L. A., Mackey, M. A., & El-Sayed, M. A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.21 · Cited by 651
Rugo, H. S., Rumble, R. B., Macrae, E., Barton, D. L., Connolly, H. K., Dickler, M. N., Fallowfield, L., Fowble, B., Ingle, J. N., Jahanzeb, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.1487 · Cited by 633
Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy
Kievit, F. M., & Zhang, M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000277 · Cited by 602
Zheng, M., Liu, S., Li, J., Qu, D., Zhao, H., Guan, X., Hu, X., Xie, Z., Jing, X., & Sun, Z. (2014) · Advanced Materials · doi:10.1002/adma.201306192 · Cited by 588
Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 575
Polymeric micelles drug delivery system in oncology
Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.012 · Cited by 570
The role of HER2 in cancer therapy and targeted drug delivery
Tai, W., Mahato, R., & Cheng, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.009 · Cited by 555
Arbab, A. S., Bashaw, L. A., Miller, B. R., Jordan, E. K., Lewis, B. K., Kalish, H., & Frank, J. A. (2003) · Radiology · doi:10.1148/radiol.2293021215 · Cited by 552
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Vallet-Regí, M., Colilla, M., Izquierdo-Barba, I., & Manzano, M. (2017) · Molecules · doi:10.3390/molecules23010047 · Cited by 538
Childs, A. C., Phaneuf, S., Dirks, A. J., Phillips, T., & Leeuwenburgh, C. (2002) · PubMed · Cited by 525
Duffy, M. J., Harbeck, N., Nap, M., Molina, R., Nicolini, A., Senkus, E., & Cardoso, F. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.01.017 · Cited by 522
Deng, Z. J., Morton, S. W., Ben-Akiva, E., Dreaden, E. C., Shopsowitz, K. E., & Hammond, P. T. (2013) · ACS Nano · doi:10.1021/nn4047925 · Cited by 516
Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles
Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., & Yang, C. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00071-6 · Cited by 513
Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., Xiao, X., Yang, Y., Sheng, W., Wu, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.006 · Cited by 511
Bharali, D. J., Lucey, D. W., Jayakumar, H., Pudavar, H. E., & Prasad, P. N. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051455x · Cited by 473
Mesoporous Silica Nanospheres as Highly Efficient MRI Contrast Agents
Taylor, K. M. L., Kim, J. S., Rieter, W. J., An, H., Lin, W., & Lin, W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710193c · Cited by 458
Schipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., et al. (2009) · Small · doi:10.1002/smll.200800003 · Cited by 452
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
Fritze, A., Hens, F., Kimpfler, A., Schubert, R., & Peschka-Süss, R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.028 · Cited by 416
Discrete Atom Imaging of One-Dimensional Crystals Formed Within Single-Walled Carbon Nanotubes
Meyer, R. R., Sloan, J., Dunin-Borkowski, R. E., Kirkland, A. I., Novotny, M. C., Bailey, S. R., Hutchison, J. L., & Green, M. L. H. (2000) · Science · doi:10.1126/science.289.5483.1324 · Cited by 414
Highly energetic compositions based on functionalized carbon nanomaterials
Yan, Q.-L., Gozin, M., Zhao, F.-Q., Cohen, A., & Pang, S.-P. (2016) · Nanoscale · doi:10.1039/c5nr07855e · Cited by 400
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Yang, T., Cui, F.-D., Choi, M.-K., Cho, J.-W., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.011 · Cited by 385
Photoluminescent Carbon Dots as Biocompatible Nanoprobes for Targeting Cancer Cells in Vitro
Li, Q., Ohulchanskyy, T. Y., Liu, R., Koynov, K., Wu, D., Best, A., Kumar, R., Bonoiu, A., & Prasad, P. N. (2010) · The Journal of Physical Chemistry C · doi:10.1021/jp911539r · Cited by 362
Bioengineering virus‐like particles as vaccines
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25159 · Cited by 355
Artemov, D., Mori, N., Okollie, B., & Bhujwalla, Z. M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10406 · Cited by 351
Kong, T., Zeng, J., Wang, X., Yang, X., Yang, J., McQuarrie, S., McEwan, A., Roa, W., Chen, J., & Xing, J. Z. (2008) · Small · doi:10.1002/smll.200700794 · Cited by 339
Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.048 · Cited by 337
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Taxol: A novel radiation sensitizer
Tishler, R. B., Schiff, P. B., Geard, C. R., & Hall, E. J. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90888-o · Cited by 319
Naumov, G. N., Townson, J. L., MacDonald, I. C., Wilson, S. M., Bramwell, V. H. C., Groom, A. C., & Chambers, A. F. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004377.12288.3c · Cited by 305
Applications of viral nanoparticles in medicine
Yildiz, I., Shukla, S., & Steinmetz, N. F. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.020 · Cited by 299
Carbon dots as a trackable drug delivery carrier for localized cancer therapy in vivo
Zeng, Q., Shao, D., He, X., Ren, Z., Ji, W., Shan, C., Qu, S., Li, J., Chen, L., & Li, Q. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01259k · Cited by 289
Kossatz, S., Grandke, J., Couleaud, P., Latorre, A., Aires, A., Crosbie-Staunton, K., Ludwig, R., Dähring, H., Ettelt, V., Lazaro-Carrillo, A., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0576-1 · Cited by 272
Dreaden, E. C., Mwakwari, S. C., Sodji, Q. H., Oyelere, A. K., & El-Sayed, M. A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9002212 · Cited by 268
In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles
Li, J.-L., Wang, L., Liu, X.-Y., Zhang, Z.-P., Guo, H.-C., Liu, W.-M., & Tang, S.-H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.09.024 · Cited by 263
Devulapally, R., Sekar, N. M., Sekar, T. V., Foygel, K., Massoud, T. F., Willmann, J. K., & Paulmurugan, R. (2015) · ACS Nano · doi:10.1021/nn507465d · Cited by 260
Viral nanoparticles as platforms for next-generation therapeutics and imaging devices
Steinmetz, N. F. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.04.005 · Cited by 259
Tsai, C.-P., Chen, C.-Y., Hung, Y., Chang, F.-H., & Mou, C.-Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b905158a · Cited by 252
Zhou, Y., Zahran, E. M., Quiroga, B. A., Perez, J., Mintz, K. J., Peng, Z., Liyanage, P. Y., Pandey, R. R., Chusuei, C. C., & Leblanc, R. M. (2019) · Applied Catalysis B: Environmental · doi:10.1016/j.apcatb.2019.02.019 · Cited by 251
Self-citationHampel, S., Kunze, D., Haase, D., Krämer, K., Rauschenbach, M., Ritschel, M., Leonhardt, A., Thomas, J., Oswald, S., Hoffmann, V., et al. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.175 · Cited by 245
Balakrishnan, S., Bhat, F. A., Raja Singh, P., Mukherjee, S., Elumalai, P., Das, S., Patra, C. R., & Arunakaran, J. (2016) · Cell Proliferation · doi:10.1111/cpr.12296 · Cited by 239
Extremely high inhibition activity of photoluminescent carbon nanodots toward cancer cells
Hsu, P.-C., Chen, P.-C., Ou, C.-M., Chang, H.-Y., & Chang, H.-T. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb00545c · Cited by 234
Recent advances in carbon based nanosystems for cancer theranostics
Augustine, S., Singh, J., Srivastava, M., Sharma, M., Das, A., & Malhotra, B. D. (2017) · Biomaterials Science · doi:10.1039/c7bm00008a · Cited by 234
Feng, T., Ai, X., Ong, H., & Zhao, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06695 · Cited by 222
Drug delivery approaches for breast cancer
Singh, S., Singh, S., Lillard Jr, J. W., & Singh, R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140325 · Cited by 219
Chen, Y., Bathula, S. R., Li, J., & Huang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125906 · Cited by 216
In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots
Yezhelyev, M. V., Al‐Hajj, A., Morris, C., Marcus, A. I., Liu, T., Lewis, M., Cohen, C., Zrazhevskiy, P., Simons, J. W., Rogatko, A., et al. (2007) · Advanced Materials · doi:10.1002/adma.200701983 · Cited by 214
Hortobagyi, G. N., Ueno, N. T., Xia, W., Zhang, S., Wolf, J. K., Putnam, J. B., Weiden, P. L., Willey, J. S., Carey, M., Branham, D. L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3422 · Cited by 208
Tsai, C., Hung, Y., Chou, Y., Huang, D., Hsiao, J., Chang, C., Chen, Y., & Mou, C. (2008) · Small · doi:10.1002/smll.200700457 · Cited by 206
Quantum Dot‐Based Nanotools for Bioimaging, Diagnostics, and Drug Delivery
Bilan, R., Nabiev, I., & Sukhanova, A. (2016) · ChemBioChem · doi:10.1002/cbic.201600357 · Cited by 195
Combination Drug Delivery Approaches in Metastatic Breast Cancer
Lee, J. H., & Nan, A. (2012) · Journal of Drug Delivery · doi:10.1155/2012/915375 · Cited by 192
Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.
Zeglinski, M. R., Lüdke, A., Jassal, D. S., & Singal, P. K. (2011) · Europe PMC (PubMed Central) · Cited by 181
Doxorubicin conjugated carbon dots as a drug delivery system for human breast cancer therapy
Kong, T., Hao, L., Wei, Y., Cai, X., & Zhu, B. (2018) · Cell Proliferation · doi:10.1111/cpr.12488 · Cited by 181
Xiao, Y., Gao, X., Taratula, O., Treado, S., Urbas, A., Holbrook, R. D., Cavicchi, R. E., Avedisian, C. T., Mitra, S., Savla, R., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-351 · Cited by 175
Polymers in Carbon Dots: A Review
Zhou, Y., Sharma, S., Peng, Z., & Leblanc, R. (2017) · Polymers · doi:10.3390/polym9020067 · Cited by 168
Self-citationCai, S., Thati, S., Bagby, T. R., Diab, H.-M., Davies, N. M., Cohen, M. S., & Forrest, M. L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.006 · Cited by 163
Phospholipid binding of annexin V: Effects of calcium and membrane phosphatidylserine content
Tait, J. F., & Gibson, D. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90111-9 · Cited by 160
Parvani, J. G., Gujrati, M. D., Mack, M. A., Schiemann, W. P., & Lu, Z.-R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3485 · Cited by 159
Carbon dots: promising biomaterials for bone-specific imaging and drug delivery
Peng, Z., Miyanji, E. H., Zhou, Y., Pardo, J., Hettiarachchi, S. D., Li, S., Blackwelder, P. L., Skromne, I., & Leblanc, R. M. (2017) · Nanoscale · doi:10.1039/c7nr05731h · Cited by 159
Self-citationPerez, E. A. (1998) · The Oncologist · doi:10.1634/theoncologist.3-6-373 · Cited by 152
Wong, M.-Y., & Chiu, G. N. C. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.02.001 · Cited by 146
EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy
Jin, H., Pi, J., Zhao, Y., Jiang, J., Li, T., Zeng, X., Yang, P., Evans, C. E., & Cai, J. (2017) · Nanoscale · doi:10.1039/c7nr06898k · Cited by 141
Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy
Le, D. H. T., Lee, K. L., Shukla, S., Commandeur, U., & Steinmetz, N. F. (2017) · Nanoscale · doi:10.1039/c6nr09099k · Cited by 139
Estrogen action: A historic perspective on the implications of considering alternative approaches
Jensen, E. V., Jacobson, H. I., Walf, A. A., & Frye, C. A. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.08.013 · Cited by 133
Rogers, W. J., & Basu, P. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.017 · Cited by 129
Novel pH sensitive N-doped carbon dots with both long fluorescence lifetime and high quantum yield
Cui, Z., An, X., & Gong, J. (2015) · RSC Advances · doi:10.1039/c5ra01986a · Cited by 129
Advances in Novel Drug Delivery Strategies for Breast Cancer Therapy
Dhankhar, R., Vyas, S. P., Jain, A., Arora, S., Rath, G., & Goyal, A. K. (2010) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.3109/10731199.2010.494578 · Cited by 128
Boman, N. L., Masin, D., Mayer, L. D., Cullis, P. R., & Bally, M. B. (1994) · PubMed · Cited by 126
Magnetic iron oxide nanoparticles as drug delivery system in breast cancer
Marcu, A., Pop, S., Dumitrache, F. V., Mocanu, M. A., Niculite, C. M., Gherghiceanu, M., Lungu, C. P., Fleaca, C. T., Ianchiş, R., Barbut, A., et al. (2013) · Applied Surface Science · doi:10.1016/j.apsusc.2013.02.072 · Cited by 122
Wáng, Y. X. J., Xuan, S., Port, M., & Idée, J. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319370003 · Cited by 120
A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer.
Greene, D., Nail, L. M., Fieler, V. K., Dudgeon, D. J., & Jones, L. S. (1994) · PubMed · Cited by 117
Online discussion of drug side effects and discontinuation among breast cancer survivors
Mao, J. J. J., Chung, A., Benton, A., Hill, S., Ungar, L., Leonard, C. E., Hennessy, S., & Holmes, J. H. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3365 · Cited by 115
Hanafi‐Bojd, M. Y., Jaafari, M. R., Ramezanian, N., Xue, M., Amin, M., Shahtahmassebi, N., & Malaekeh‐Nikouei, B. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.009 · Cited by 112
Shao, W., Paul, A., Zhao, B., Lee, C., Rodes, L., & Prakash, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.007 · Cited by 102
Mu, Q., Kievit, F. M., Kant, R. J., Lin, G., Jeon, M., & Zhang, M. (2015) · Nanoscale · doi:10.1039/c5nr04867b · Cited by 101
Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles
Jin, G., He, R., Liu, Q., Dong, Y., Lin, M., Li, W., & Xu, F. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b14603 · Cited by 100
Faraj, A. A., Shaik, A. P., & Shaik, A. S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s75074 · Cited by 97
Drug-loaded gold plasmonic nanoparticles for treatment of multidrug resistance in cancer
Lee, S., Kim, H. J., Kim, S. Y., Kwon, M. K., Kim, S., Cho, A. E.-H., Yun, M., Shin, J., & Yoo, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.068 · Cited by 94
A7RC peptide modified paclitaxel liposomes dually target breast cancer
Cao, J., Wang, R., Gao, N., Li, M., Tian, X., Yang, W., Ruan, Y., Zhou, C., Wang, G., Liu, X., et al. (2015) · Biomaterials Science · doi:10.1039/c5bm00161g · Cited by 93
Evaluation of the genotoxicity of cellulose nanofibers
de Lima, R., Mattoso, L. H. C., Feitosa, MARUYAMA, M., Barga, Yamawaki, Vieira, Teixeira, & Fraceto, L. F. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30596 · Cited by 86
Hua, M., Yang, H., Liu, H.-L., Tsai, R., Pang, S., Chuang, K., Chang, Y., Hwang, T., Chang, Y., Chuang, H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.014 · Cited by 85
Poller, J. M., Zaloga, J., Schreiber, E., Unterweger, H., Janko, C., Radon, P., Eberbeck, D., Trahms, L., Alexiou, C., & Friedrich, R. P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132369 · Cited by 83
Challenges in the Use of Carbon Nanotubes for Biomedical Applications
Mehra, N. K., Jain, A., Lodhi, N., Raj, R., Dubey, V., Mishra, D. K., Nahar, M., & Jain, N. K. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i2.20 · Cited by 79
Truffi, M., Colombo, M., Sorrentino, L., Pandolfi, L., Mazzucchelli, S., Pappalardo, F., Pacini, C., Allevi, R., Bonizzi, A., Corsi, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24968-x · Cited by 79
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery
Hayes, M. E., Drummond, D. C., Kirpotin, D. B., Zheng, W. W., Noble, C. O., Park, J. W., Marks, J. D., Benz, C. C., & Hong, K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302699 · Cited by 77
Zhang, W., Wang, R., Liu, W., Wang, X., Li, P., Zhang, W., Wang, H., & Tang, B. (2017) · Chemical Science · doi:10.1039/c7sc03878j · Cited by 72
Targeting the Estrogen Receptor using Steroid–Therapeutic Drug Conjugates (Hybrids)
Dao, K.-L., & Hanson, R. N. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300378e · Cited by 68
Wang, L., Peng, C., Chen, C., & Li, Y. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3363-x · Cited by 67
Neves, L. F. F., Krais, J. J., Rite, B. D. V., Ramesh, R., Resasco, D. E., & Harrison, R. G. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/37/375104 · Cited by 66
Gel‐like Carbon Dots: Characterization and their Potential Applications
Zhou, Y., Desserre, A., Sharma, S. K., Li, S., Marksberry, M. H., Chusuei, C. C., Blackwelder, P. L., & Leblanc, R. M. (2017) · ChemPhysChem · doi:10.1002/cphc.201700038 · Cited by 66
Self-citationYou, Y., Xu, Z., & Chen, Y. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435746 · Cited by 65
Photoluminescent Carbon Dots: A Mixture of Heterogeneous Fractions
Zhou, Y., Liyanage, P. Y., Geleroff, D. L., Peng, Z., Mintz, K. J., Hettiarachchi, S. D., Pandey, R. R., Chusuei, C. C., Blackwelder, P. L., & Leblanc, R. M. (2018) · ChemPhysChem · doi:10.1002/cphc.201800248 · Cited by 63
Self-citationPandey, S. K., Patel, D. K., Maurya, A. K., Thakur, R. K., Mishra, D. P., Vinayak, M., Haldar, C., & Maiti, P. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.065 · Cited by 60
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles
Scarberry, K. E., Dickerson, E. B., Zhang, Z. J., Benigno, B. B., & McDonald, J. F. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.11.003 · Cited by 58
Şalva, E., Turan, S. Ö., Eren, F., & Akbuğa, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.065 · Cited by 53
Radenković, D., Kobayashi, H., Remsey-Semmelweis, E., & Seifalian, A. M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.02.014 · Cited by 50
Patel, J. M., Vartabedian, V. F., Kim, M., He, S., Kang, S., & Selvaraj, P. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25537 · Cited by 49
Lipid-based nanoparticles as drug delivery system for paclitaxel in breast cancer treatment
Marcial, S. P. D. S., Carneiro, G., & Leite, E. A. (2017) · Journal of Nanoparticle Research · doi:10.1007/s11051-017-4042-0 · Cited by 48
Engineering Recombinant Virus-like Nanoparticles from Plants for Cellular Delivery
Brillault, L., Jutras, P. V., Dashti, N. H., Thuenemann, E. C., Morgan, G., Lomonossoff, G. P., Landsberg, M. J., & Sainsbury, F. (2017) · ACS Nano · doi:10.1021/acsnano.6b07747 · Cited by 46
Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression
Hurst, D. R., & Welch, D. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.045 · Cited by 45
Targeting Breast Cancer with Sugar-Coated Carbon Nanotubes
Fahrenholtz, C. D., Hadimani, M. B., King, S. B., Torti, S. V., & Singh, R. N. (2015) · Nanomedicine · doi:10.2217/nnm.15.90 · Cited by 42
Li, Y., Humphries, B. A., Yang, C., & Wang, Z. (2018) · Nanomaterials · doi:10.3390/nano8060361 · Cited by 42
Targeted Drug Delivery for Breast Cancer Treatment
Jin, S., & Ye, K. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892811308020003 · Cited by 40
Nishimura, Y., Mieda, H., Ishii, J., Ogino, C., Fujiwara, T., & Kondo, A. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-19 · Cited by 39
A cancer source book for nurses
Varricchio, C. G. (1997) · American Cancer Society eBooks · Cited by 33
Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
Saulīte, L., Pleiko, K., Popēna, I., Dapkutė, D., Rotomskis, R., & Riekstiņa, U. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.32 · Cited by 33
Karahaliloğlu, Z., Kılıçay, E., Alpaslan, P., Hazer, B., & Denkbaş, E. B. (2017) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911517710811 · Cited by 29
Tamoxifen and its New Derivatives in Cancer Research
Rivera-Guevara, C., & Camacho, J. (2011) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489211795328486 · Cited by 27
Targeting breast cancer cells with a CuInS2/ZnS quantum dot-labeled Ki-67 bioprobe
Sun, G., Xing, W., Xing, R., Liu, C., Tong, S., & Yu, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.7615 · Cited by 25
Korkeila, E. A., Sundström, J. T. T., Pyrhönen, S. O., & Syrjänen, K. J. (2011) · PubMed · Cited by 23
Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment
Wang, Y. K., Wang, C., Jia, Y., Cheng, X., Lin, Q., Zhu, M., Lu, Y., Ding, L., Weng, Z., & Wu, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104209 · Cited by 20
Rathinaraj, P., -Jumaily, A. A., & Huh, D. S. (2015) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s69834 · Cited by 19
The Hyperplastic Phenotype in PR-A and PR-B Transgenic Mice
Sampayo, R. G., Recouvreux, S., & Simian, M. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00012-5 · Cited by 15
A Cancer Source Book for Nurses
&NA; (1951) · AJN American Journal of Nursing · doi:10.1097/00000446-195104000-00062 · Cited by 11
Cited by
Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 768
Preparation and application of pH-responsive drug delivery systems
Ding, H., Tan, P., Fu, S., Tian, X., Zhang, H., Ma, X., Gu, Z., & Luo, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.056 · Cited by 645
Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
Siddique, S., & Chow, J. C. L. (2020) · Nanomaterials · doi:10.3390/nano10091700 · Cited by 402
Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment
Herdiana, Y., Wathoni, N., Shamsuddin, S., Joni, I. M., & Muchtaridi, M. (2021) · Polymers · doi:10.3390/polym13111717 · Cited by 196
Drug delivery based on stimuli-responsive injectable hydrogels for breast cancer therapy: A review
Xin, H., & Naficy, S. (2022) · Gels · doi:10.3390/gels8010045 · Cited by 83
Metadata
- Authors
- Liyanage, P. Y., Hettiarachchi, S. D., Zhou, Y., Ouhtit, A., Seven, E. S., Oztan, C. Y., Celik, E., & Leblanc, R. M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 1871
- Issue
- 2
- Pages
- 419-433
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2942110717
- Cited by
- 287
- References
- 156
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.